المؤلفون: Kroese, TE, van Laarhoven, HWM, Schoppman, SF, Deseyne, PRAJ, van Cutsem, E, Haustermans, K, Nafteux, P, Thomas, M, Obermannova, R, Mortensen, HR, Nordsmark, M, Pfeiffer, P, Elme, A, Adenis, A, Piessen, G, Bruns, CJ, Lordick, F, Gockel, I, Moehler, M, Gani, C, Liakakos, T, Reynolds, J, Morganti, AG, Rosati, R, Castoro, C, Cellini, F, D'Ugo, D, Roviello, F, Bencivenga, M, de Manzoni, G, Henegouwen, MIV, Hulshof, MCCM, van Dieren, J, Vollebergh, M, van Sandick, JW, Jeene, P, Muijs, CT, Slingerland, M, Voncken, FEM, Hartgrink, H, Creemers, GJ, van der Sangen, MJ, Nieuwenhuijzen, G, Berbee, M, Verheij, M, Wijnhoven, B, Beerepoot, LV, Mohammad, NH, Mook, S, Ruurda, JP, Kolodziejczyk, P, Polkowski, WP, Wyrwicz, L, Alsina, M, Pera, M, Kanonnikoff, TF, Cervantes, A, Nilsson, M, Monig, S, Wagner, AD, Guckenberger, M, Griffiths, EA, Smyth, E, Hanna, GB, Markar, S, Chaudry, MA, Hawkins, MA, Cheong, ED, van Hillegersberg, R, van Rossum, PSN

المصدر: European journal of cancer (Oxford, England : 1990). 185:28-39

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:152780818

المؤلفون: Laan, van der, Hans Paul, Anakotta, Melissa, Korevaar, Erik, Dieters, Margriet, Ubbels, Fred, Langendijk, J.A., Muijs, CT, Knopf, Antje

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: the 57th Annual Meeting of the Particle Therapy Cooperative Group (PTCOG)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::ce272e3fafa1a9ff7c371c69a40a214c
https://research.rug.nl/en/publications/91f268b4-e2ab-4449-a5f8-fb40e854e14d

المؤلفون: Berbée M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands. Electronic address: maaike.berbee@maastro.nl., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Schuit E; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Apr; Vol. 193, pp. 110176. Date of Electronic Publication: 2024 Feb 18.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms* , Esophageal Neoplasms*, Humans ; Lung

المؤلفون: Berbée M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands. Electronic address: maaike.berbee@maastro.nl., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Voncken FEM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Wee L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands., Sosef M; Department of Surgery, Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands., van Etten B; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands., van Sandick JW; Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands., Warmerdam FARM; Department of Medical Oncology, Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Oldehinkel E; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., van Dieren JM; Department of Gastroenterology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Boersma L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., van der Schaaf A; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Reitsma JB; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, the Netherlands., Schuit E; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109979. Date of Electronic Publication: 2023 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Esophageal Neoplasms*/therapy, Humans

المؤلفون: Mortensen HR; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Populaire P; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Hoffmann L; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Moeller DS; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Appelt A; University of Leeds, Leeds, UK., Nafteux P; University Hospitals Leuven, Department of Thoracic Surgery, Belgium., Muijs CT; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Grau C; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, London, UK., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany., Defraene G; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, the Netherlands., Clarke CS; Research Dept. of Primary Care and Population Health, University College London, London, UK., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland., Korevaar EW; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Haustermans K; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium., Nordsmark M; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Achiam MP; Dept. Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Markar SR; Department of General Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgery, University of Oxford, Oxford, UK., Radhakrishna G; The Christie, Manchester, United Kingdom., Berbee M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Scartoni D; Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Orlandi E; National Center for Oncological Hadrontherapy (CNAO), Radiation Oncology Clinical Department, Pavia, Italy., Doyen J; Centre Antoine Lacassagne, Nice, France., Gregoire V; Centre Léon Bérard, 28 rue Laennec, Lyon 69373 Cedex 08, France., Crehange G; PSL Research University, RadiationOncology Department, Institut Curie, Paris/Orsay, France., Langendijk J; Department of Radiation Oncology, UniversityMedicalCentreGroningen, Groningen, The Netherlands., Lorgelly P; University of Auckland, Waipara Taumata Rau, Auckland, New Zealand., Blommenstein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR, The Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands., Byskov CS; Department of Oncology and Medical physics, Aarhus University Hospital, Aarhus, Denmark., Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Jensen MF; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Freixas GV; Maastro Proton Therapy, Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden-Rossendorf, Germany.

مؤلفون مشاركون: PROTECT consortium

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109980. Date of Electronic Publication: 2023 Nov 05.

نوع المنشور: Clinical Trial Protocol; Letter

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/surgery , Neoadjuvant Therapy*, Humans ; Chemoradiotherapy ; Esophagectomy ; Protons ; Clinical Trials, Phase III as Topic ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

المؤلفون: Niezink AGH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: a.g.h.niezink@umcg.nl., van der Schaaf A; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Wijsman R; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Chouvalova O; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Rutgers SR; Department of Pulmonology, Treant Hospital Group, Scheper Hospital, Emmen, the Netherlands., Pieterman RM; Department of Pulmonary Diseases, Ommelander Hospital Groningen, Scheemda, the Netherlands., van Putten JWG; Department of Pulmonary Diseases, Martini Hospital Groningen, Groningen, the Netherlands., de Hosson SM; Department of Pulmonary Diseases, Wilhelmina Hospital Assen, Assen, the Netherlands., van der Leest AHD; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Ubbels JF; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Woltman-van Iersel M; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Widder J; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Radiation Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria., Langendijk JA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Muijs CT; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Sep; Vol. 186, pp. 109735. Date of Electronic Publication: 2023 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiation Pneumonitis*/diagnosis , Radiation Pneumonitis*/epidemiology , Radiation Pneumonitis*/etiology , Lung Neoplasms*/radiotherapy, Humans ; Prospective Studies ; Probability ; Chemoradiotherapy/adverse effects ; Radiotherapy Dosage

المؤلفون: Visser S; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: s.visser01@umcg.nl., Korevaar EW; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Wijsman R; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Pisciotta P; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Gutteres Marmitt G; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., O Ribeiro C; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Both S; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 May; Vol. 182, pp. 109575. Date of Electronic Publication: 2023 Feb 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Thoracic Neoplasms*/diagnostic imaging , Thoracic Neoplasms*/radiotherapy , Proton Therapy*/methods , Radiotherapy, Intensity-Modulated*/methods, Humans ; Protons ; Radiotherapy Planning, Computer-Assisted/methods ; Four-Dimensional Computed Tomography/methods ; Radiotherapy Dosage

المؤلفون: Visser S; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands. Electronic address: s.visser01@umcg.nl., O Ribeiro C; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Dieters M; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Mul VE; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., van der Schaaf A; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Knopf AC; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands; Department of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital of Cologne, Cologne, Germany., Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Korevaar EW; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Both S; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Dec; Vol. 177, pp. 197-204. Date of Electronic Publication: 2022 Nov 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy, Intensity-Modulated*/methods , Proton Therapy*/methods , Esophageal Neoplasms*/radiotherapy, Humans ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy Dosage ; Protons ; Organs at Risk

المؤلفون: Hoffmann L; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark. Electronic address: Lone.Hoffmann@aarhus.rm.dk., Mortensen H; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Shamshad M; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Berbee M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Bizzocchi N; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Defraene G; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium., Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark., Fiorini F; Rutherford Cancer Centre, Shinfield, Reading, UK., Haustermans K; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Hulley R; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Korevaar EW; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Clarke M; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Makocki S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Murray L; Rutherford Cancer Centre, Shinfield, Reading, UK., Nicholas O; South West Wales Cancer Centre, Swansea University Board and Swansea University Medical School, UK., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Radhakrishna G; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Thomas M; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Vilches-Freixas G; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Visser S; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland., Møller DS; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Jul; Vol. 172, pp. 32-41. Date of Electronic Publication: 2022 May 02.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/diagnostic imaging , Esophageal Neoplasms*/radiotherapy , Proton Therapy*/methods , Radiotherapy, Intensity-Modulated*/methods, Humans ; Protons ; Radiotherapy Planning, Computer-Assisted/methods

المؤلفون: Faiz Z; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kats-Ugurlu G; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mui VEM; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Karrenbeld A; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Burgerhof HGM; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Plukker JTM; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

المصدر: Annals of surgery [Ann Surg] 2022 Jun 01; Vol. 275 (6), pp. e759-e765. Date of Electronic Publication: 2020 Jul 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1140 (Electronic) Linking ISSN: 00034932 NLM ISO Abbreviation: Ann Surg Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy, Adjuvant* , Esophageal Neoplasms*, Chemoradiotherapy ; Humans ; Neoadjuvant Therapy ; Neoplasm Staging ; Neoplasm, Residual/pathology